One-Year Outcomes of the PAUL Glaucoma Implant Compared With the Ahmed Glaucoma Valve for the Treatment of Silicone Oil Glaucoma

被引:0
|
作者
Karapapak, Murat [1 ]
Olgun, Ali [2 ]
机构
[1] Univ Hlth Sci, Basaksehir Cam & Sakura City Hosp, Dept Ophthalmol, Basaksehir Olymp Blvd Rd, TR-34480 Istanbul, Turkiye
[2] West Eye Hosp, Dept Ophthalmol, Erbil, Iraq
关键词
Ahmed glaucoma valve; emulsified silicone oil; PAUL glaucoma implant; secondary glaucoma; PARS-PLANA VITRECTOMY; INTRAOCULAR-PRESSURE; DRAINAGE DEVICES; INJECTION; MANAGEMENT; COMPLICATIONS; SURGERY; EYES;
D O I
10.1097/IJG.0000000000002360
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis: Longer-term studies with a larger sample size are needed to demonstrate the superiority or equivalence of these procedures. Objective: To evaluate the outcomes of the PAUL glaucoma implant (PGI) and Ahmed glaucoma valve (AGV) in patients with secondary glaucoma caused due to silicone oil emulsification. Patients and Methods: A retrospective examination was conducted using the medical records of 36 patients who developed secondary glaucoma due to silicone oil emulsification after vitreoretinal surgery and then underwent PGI and AGV implantation surgery. The main outcome measures in the PGI and AGV groups were intraocular pressure (IOP) and its change, the number of antiglaucoma medications, and postoperative complications during the 12-month follow-up period. IOP of <6 mm Hg is used to define hypotonia. Results: There was no statistically significant difference among the patients who underwent PGI and AGV surgeries in terms of IOP averages, both preoperatively and postoperatively on day 1, week 1, month 1, month 3, month 6, and month 12 (P > 0.05). Before PGI and AGV implantation, the mean IOP was 40 +/- 13 mm Hg and 39.3 +/- 10 mm Hg, and the mean number of medications was 3.8 +/- 0.4 and 4 +/- 0, respectively. At the end of the 12-month follow-up period, the mean IOP was 13.5 +/- 2.2 (P < 0.001) mm Hg and 14.9 +/- 4.2 (P < 0.001) mm Hg, whereas the mean number of glaucoma medications decreased to 1.7 +/- 1.3 (P < 0.001) and 1.9 +/- 1.8 (P < 0.001) in the PGI and AGV groups, respectively. Surgical success was achieved in 17 of 18 eyes (94%) in the PGI group and 16 of 18 eyes (89%) in the AGV group. Conclusions: Although the outcomes were similar in both the PGI and AGV groups, complications requiring medical and surgical intervention were less common in the PGI group. Longer-term studies with a larger sample size are needed to demonstrate the superiority or equivalence of these procedures.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 50 条
  • [1] Clinical outcomes of the PAUL® glaucoma implant: One-year results
    Weber, Constance
    Hundertmark, Sarah
    Liegl, Raffael
    Jauch, Anna S.
    Stasik, Isabel
    Holz, Frank G.
    Mercieca, Karl
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (06): : 566 - 576
  • [2] Surgical Outcomes of a Second Ahmed Glaucoma Valve Implant for the Treatment of Refractory Glaucoma
    Becerril-Cazadero, Roxana
    Seibold, Leonard K.
    Turati-Acosta, Mauricio
    Jimenez-Roman, Jesus
    Fabre-Miranda, Karina
    Han, Ying
    Lazcano-Gomez, Gabriel
    JOURNAL OF GLAUCOMA, 2020, 29 (10) : 948 - 951
  • [3] Outcomes of Silicone Ahmed Glaucoma Valve Implantation in Refractory Pediatric Glaucoma
    Senthil, Sirisha
    Turaga, Kiranmaye
    Mohammed, Hasnat A.
    Krishnamurthy, Rashmi
    Badakere, Swathi
    Dikshit, Siddharth
    Choudhari, Nikhil
    Mandal, Anil K.
    Garudadri, Chandra S.
    JOURNAL OF GLAUCOMA, 2018, 27 (09) : 769 - 775
  • [4] Three-Year Outcomes of the Paul Glaucoma Implant for Treatment of Glaucoma
    Tan, Marcus Chun Jin
    Ong, Chee Wui
    Aquino, Maria Cecilia
    Lun, Katherine Wanxian
    Sng, Chelvin Cheryl Agnes
    Lim, Dawn Ka Ann
    Loon, Seng Chee
    Koh, Victor Teck Chang
    Chew, Paul Tec Kuan
    JOURNAL OF GLAUCOMA, 2024, 33 (07) : 478 - 485
  • [5] Two-Year Outcomes of the Paul Glaucoma Implant for Treatment of Glaucoma
    Tan, Marcus Chun Jin
    Choy, Heng Yoong Chloe
    Chang, Victor Koh Teck
    Aquino, Maria Cecilia
    Sng, Chelvin Cheryl Agnes
    Lim, Dawn Ka Ann
    Loon, Seng Chee
    Kuan, Paul Chew Tec
    JOURNAL OF GLAUCOMA, 2022, 31 (06) : 449 - 455
  • [6] Baerveldt Glaucoma Implant versus Ahmed Glaucoma Implant in a One-Year Follow Up, Comparative Study
    Elbaklish, Khaled Hamdi
    Saleh, Safaa Mohammed
    Gomaa, Wael Adel
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 29 - 39
  • [7] One year outcomes of the PAUL glaucoma implant in comparison to the Baerveldt glaucomaimplant for glaucoma
    Scheres, L. M. J.
    Komljanc, E. Pelko
    Berendschot, T. T. J. M.
    Beckers, H. J. M.
    ACTA OPHTHALMOLOGICA, 2023, 101 : 17 - 17
  • [8] A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma
    Ayyala, RS
    Zurakowski, D
    Smith, JA
    Monshizadeh, R
    Netland, PA
    Richards, DW
    Layden, WE
    OPHTHALMOLOGY, 1998, 105 (10) : 1968 - 1976
  • [9] Ahmed Glaucoma Valve Surgical Outcomes in Eyes With and Without Silicone Oil Endotamponade
    Ishida, Kyoko
    Ahmed, Iqbal Ike K.
    Netland, Peter A.
    JOURNAL OF GLAUCOMA, 2009, 18 (04) : 325 - 330
  • [10] A comparison of the polypropylene plate Ahmed™ glaucoma valve to the silicone plate Ahmed™ glaucoma flexible valve
    Hinkle, D. M.
    Zlirakoinski, D.
    Ayyala, R. S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (05) : 696 - 701